RESPPEDHEM
Prospective Study of Late Pulmonary Complications Occurring in Children Treated With Allogeneic Hematopoietic Stem Cells.
Sponsor study identifier
Secondary identifiers
OTHER · APHP
interventional
300
1 country
1
Study Start
January 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 30, 2020
Actual (reported)Study Completion
March 30, 2020
Actual (reported)Hematopoietic stem cell transplantation (HSCT) is used to treat an expanding array of malignant and non-malignant disorders. This is a prospective multicenter study, in pediatric allo-BMT recipients to analyze the spectrum of noninfectious pulmonary complications (PC), to evaluate the prevalence and course of PFT abnormalities before and after transplant, and to detect risk factor for PC.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 30, 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 9, 2013
Actual (reported)January 2014
Date type not reportedThis date has not been verified as actual or estimated.
January 10, 2014
Actual (reported)March 30, 2020
Actual (reported)March 30, 2020
Actual (reported)Presence of belated non-infectious pulmonary complications
3 years
Presence of risk factors for belated non-infectious pulmonary complications
3 years
Survival three years
3 years
Severity of respiratory disease
3 years
The eligible population for this study will consist of all children under 18 years who received allogeneic hematopoietic stem cell and evaluate of late pulmonary complications occurring in children treated with allogeneic hematopoietic stem cells.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Houdouin véronique
Paris, 75019, France
Houdouin V, Feghali H, Boileau S, Guinot M, Reix P, Pages J, Crepon SG, Delclaux C. Prospective Evaluation of Cardiorespiratory Fitness After Hematopoietic Stem Cell Transplantation in Children. Pediatr Pulmonol. 2025 May;60(5):e70994. doi: 10.1002/ppul.70994.
Houdouin V, Dubus JC, Crepon SG, Rialland F, Bruno B, Jubert C, Reix P, Pasquet M, Paillard C, Adjaoud D, Schweitzer C, Le Bourgeois M, Pages J, Yacoubi A, Dalle JH, Bergeron A, Delclaux C. Late-onset pulmonary complications following allogeneic hematopoietic cell transplantation in pediatric patients: a prospective multicenter study. Bone Marrow Transplant. 2024 Jun;59(6):858-866. doi: 10.1038/s41409-024-02258-7. Epub 2024 Mar 7.
Houdouin Véronique, MD PHD
APHP
300 participants (actual enrollment reported by the registry).
First Submitted
December 9, 2013
First Posted
January 10, 2014
Study Start
January 2014
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
March 30, 2020
Actual (reported)Study Completion
March 30, 2020
Actual (reported)Last Updated
April 29, 2020
Record last verified: 2020-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: